Akorn Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Akorn Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (77)	11/10/1999 3:21:00 PM
From: scaram(o)uche	Read Replies (1) of 101

biz.yahoo.com In LATU041, Photogen Signs Agreement with Akorn Inc. to Develop PH-10 For Non-Invasive Oncology and Dermatology Treatments, moved yesterday, Nov. 9, the following sentence, which should follow the bullet points, was inadvertently omitted by PR Newswire: "Together, existing treatments for these three indications represent a multi-billion dollar market."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next